The Dow Jones Industrial Average finished with a tiny gain of less than 0.1% in the current stock market session. Boeing (BA) soared as many as 18 points and is testing resistance at its 200-day moving average after announcing plans to get its 737 MAX jets back in commercial service early next year.
XThe Russell 2000 had initially led the upside, but then lagged with a nearly 0.3% loss.
Boeing is still forming a base. No IBD-style buy point has emerged yet.
Ditto for Trade Desk (TTD), which rallied more than 10% higher in volume running twice its 50-day average. It's rode to the top of IBD's Stocks On The Move table. That's definitely positive price-and-volume action.
But the innovator in AI-driven ad buying platforms across all media channels is now just trying to hoist itself back above the falling 50-day moving average.
Watch to see if TTD can keep rebounding, clear through overhead supply, and finish a good base. That hard work by the stock may culminate in a new breakout and a correct buy point that would generate a higher probability of further price gains and ultimately new highs.
The Ventura, Calif., company is making a big bet on China.
The S&P 500 and the Nasdaq composite nursed small losses in the 0.1%-0.2% range. The U.S. stock market remains in a confirmed uptrend.
The Nasdaq has risen six weeks in a row, including three straight weeks of 1% advances or more. Volume fell on both main exchanges vs. Friday, according to early data.
Meanwhile, top growth stocks continued to show nice mojo.
Beyond Dow Jones: Leading Stocks Today
On Leaderboard, Copart (CPRT) and Inphi (IPHI) led the way with gains of nearly 2% to 3%.
See their special chart annotations on Leaderboard to spot the correct buy point, when to sell and other notable price-and-volume action.
Tempur-Sealy (TPX) and Lululemon (LULU), both in Leaderboard too as half-size positions, each gained 1%. They are reflecting continued appetite among institutional investors for fast-growing companies in the consumer spending and retail sectors.
Acadia Pharmaceuticals (ACAD), highlighted in today's IBD Live talk show (running from 9:20 a.m. to around 10:30 a.m. ET), surged nearly 7% in big volume. That sent shares rolling past a 44.20 buy point in a nearly eight-week cup with handle. Shares have climbed 183% year to date.
Read more about this emerging stock market leader and treatment specialist for patient psychosis in IBD Stock Of The Day.
According to IBD Stock Checkup, Acadia gets a respectable 87 Composite Rating on a scale of 1 (regrettable) to 99 (redoubtable). In most cases, eye those stocks with a 90 IBD Composite Rating or higher. In Acadia's case, a poor Earnings Per Share Rating of 43 hurts the stock's overall composite score for fundamental, stock price action, and institutional sponsorship factors.
Innovator IBD 50 (FFTY) rose 1.1%.
InMode (INMD), highlighted in this Big Picture column as it triggered two very important rules on when to hold for eight weeks and when to sell, SolarEdge Technologies (SEDG) and Essential Properties Realty (EPRT) made outsized gains to hoist FFTY higher than the key indexes.
In Other Financial Markets
The yield on the benchmark U.S. Treasury 10-year bond is holding steady at 1.94%. That's sharply up from 1.73% at the start of November. Lately, the yield curve has adopted a more bank-friendly positive slope.
While 3-month T-bills yield 1.54%, two-year notes offer 1.67%.
Please follow Chung on Twitter at @SaitoChung and @IBD_DChung for more on growth stocks, buy points, sell rules, breakouts, chart analysis and stock market insight.
YOU MIGHT ALSO LIKE:
These 6 Stocks Cleared Or Held Buy Points
Join IBD Live And Learn Top Chart-Reading And Trading Techniques From The Pros
How To Find The Next Apple, Amazon, Microsoft, Home Depot: Start With A Simple Routine
Current Top Stocks In IBD Leaderboard
Also In Stock Market Today: Boeing Up, But This Is Why It's Still Not At A Buy Point
